3811 results for «2272»
3811 results
Welcome introduction
15 May 2017 – From PCR Innovators Day 2017
Discover the latest innovative and disruptive technologies and key opinion leaders in interventional cardiology during the opening ceremony by W Wijns during PCR Innovators Day Paris 2017.
EAPCI Fellows Course - Opening
15 May 2017 – From EuroPCR 2017
Welcome to the European Interventional Cardiology Fellows Course - Opening, consult this session if you want to find out more about the course hosted by the European Association of Percutaneous Cardiovascular Interventions (EAPCI) on Monday 15 and Tuesday morning 16 May.
These presentations were part of the EAPCI...
EuroPCR 2017 Opening Ceremony
16 May 2017 – From EuroPCR 2017
A warm welcome from the Course Directors J. Bax, J. Fajadet, W. Wijns to everyone attending the 2017 edition of EuroPCR that marks 40 years in Angioplasty. Enjoy the Course!
EuroPCR 2017 Nurses and Allied Professionals Programme Closing Ceremony
19 May 2017 – From EuroPCR 2017
Consult the session on the Closing Ceremony of the EuroPCR 2017 Nurses and Allied Professionals Programme, presented by S. Coelho, H. Eltchaninoff and D. Sparv. The State-of-the-art lecture on structural heart disease by Prof. A. Cribier sheds light on LAA occlusion.
EuroPCR 2017 Closing Ceremony
19 May 2017 – From EuroPCR 2017
Left ventricular and systolic dimension determines anatomic suitability for transcatheter mitral valve implantation
25 Jun 2020 – From PCR e-Course 2020
A common exclusion for transcatheter mitral valve implantation (TMVI) is a small predicted neo-left ventricular outflow tract (LVOT). Simulation of the neoLVOT is time-consuming, requires multi-detector computerised tomography (MDCT), specialised software, and computer models of the prosthesis. Measurements that do not require neoLVOT simulation may provide...
New TMVI therapy to eliminate mitral regurgitation. Evidence and patient selection
26 Jun 2020 – From PCR e-Course 2020
Watch this video if you want to get the latest update on the first commercially available TMVI therapy (Tendyne), to learn about Tendyne clinical experience and how to identify the best candidates for this novel therapy.
Two-year outcomes of Tendyne Transcatheter Mitral Valve Implementation (TMVI) to treat symptomatic severe mitral regurgitation
Learn more about the 2-year outcomes of the first 100 patients treated as part of the Tendyne Expanded Clinical Study, and how the latest Tendyne clinical evidence may change the way the heart team treats mitral regurgitation.
Videos included on this page: the Hot Line presentation and...
Shaping care pathways for severe aortic stenosis patients in a COVID-19 context
Watch this roundtable discussion on the management of aortic stenosis in the context of the COVID-19 pandemic and how to readdress the treatment options and pathways to serve the needs of the patients in this difficult global crisis.
Portico FlexNav - Optimise TAVI outcomes from routine to complex cases
Watch this session if you want to learn how Portico enables you to achieve favorable haemodynamics and patient outcomes, to learn about the new Portico with FlexNav TAVI system and its deliverability and to learn the importance of looking ahead during transcatheter aortic valve implantation and...
Hot lines on Mitral interventions – part 1
25 Jun 2020 – From PCR e-Course 2020
Watch a series of Hot Lines on mitral interventions presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: EVOQUE replacement, Tendyne TMVI, CLASP, V-i-V and V-i-R, Tendyne MAC.
PCR e-Course 2020 Late-Breaking Trials – part 1
26 Jun 2020 – From PCR e-Course 2020
Watch a series of Late-Breaking Trials presented during the PCR e-Course 2020 and see how they might have an impact on your practice:
- Crossover results from the RADIANCE-HTN SOLO trial
- DynamX Bioadaptor, a novel « uncaging » platform
- Two-stent vs. provisional for bifurcation PCI: the DEFINITION II trial
PCR e-Course 2020 Hot lines: TAVI – part 2
26 Jun 2020 – From PCR e-Course 2020
Watch a series of Hot Lines on TAVI presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: PORTICO IDE, FlexNav Delivery System, FRANCE TAVI, BIVOLUT-X, VIVALL.
PCR e-Course Hot lines on TAVI – part 1
25 Jun 2020 – From PCR e-Course 2020
Watch a series of Hot Lines on TAVI presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: Evolut Low-Risk trial, MyVal-1 study, BASILICA vs. control, non-invasive ultrasound therapy, long-term outcomes after V-i-V.
Hot lines on tricuspid interventions
Watch a series of Hot Lines on repair techniques for tricuspid regurgitation presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: Transferomal TTVR with EVOQUE, STTAR, TRILUMINATE.
Revascularisation strategies - PCR e-Course 2020 Hot lines
29 Jul 2020 – From PCR e-Course 2020
Watch a series of Hot Lines on revascularisation presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: ISIS II, REDUCER-I, RINCAL, SYNTAX score II 2020.
Mitral interventions - part 2: Global EXPAND registry
25 Jun 2020 – From PCR e-Course 2020
Watch this session to find out more on clip selection strategy and the safety and effectiveness of the MitraClip XTR System: Results and recommendations from the Global EXPAND Study.
This session was originally presented during PCR e-Course 2020.
CT guidance for coronary interventions - PCR e-Course 2020 Hot lines
26 Jun 2020 – From PCR e-Course 2020
Watch a series of Hot Lines on CT-guidance for PCI presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: CT-FFR CHINA, CAST-FFR, CT-QFR vs. myocardial perfusion imaging, CT-CTO trial, CCTA for optimal fluoroscopic coronary projections.
Hot line on PCI: high bleeding risk and DAPT - part 1
26 Jun 2020 – From PCR e-Course 2020
Watch a series of Hot Lines on high bleeding risk and DAPT presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: ARC-HBR, MODEL U-SES, Onyx ONE trials.
PCR e-Course 2020 Late-Breaking Trials - part 2
26 Jun 2020 – From PCR e-Course 2020
Watch a series of Late-Breaking Trials presented during the PCR e-Course 2020 and see how they might have an impact on your practice:
- 2-year safety of revascularisation deferral based on iFR or FFR
- CABG and PCI in patients with CTO and multivessel disease
- Routine revascularisation vs. medical therapy
